Laura Mercolini, Silvia Bittner Fialová, Martin Doseděl, Marianna Kocsis, Tímea Bencsik, József Szentpéteri, Milan Nagy, Ágnes Farkas, Györgyi Horváth, Szilvia Czigle, Michele Protti, Viktória Lilla Balázs, Kamilla Ács, Adrienn Horváth, Eszter Csikós, Přemysl Mladěnka, Jaroslav Tóth
Journal: Fitoterapia 2024;179():106256
PMID: 39419127
The prevalence of chronic venous disease (CVD) is relatively high, it affects 20-80 % of the population worldwide. CVD may affect any veins in the human body, however, the veins of the lower extremities are the most susceptible to this condition. Among therapeutic possibilities for CVD, mainly chronic venous insufficiency, some medicinal plants (Ruscus aculeatus L., Aesculus hippocastanum L., Centella asiatica (L.) Urb.) and their active compounds (ruscoside, aescin, asiaticoside) or close derivatives also have important places. This review describes shortly the updated knowledge on pathophysiology, clinical manifestations, evaluation, and diagnostics of CVD as well as treatment modalities. The primary focus of this review is on the existing knowledge about botanical medications for treating chronic venous disease (CVD). It covers the chemical makeup of these plant drugs, their pharmacological effects, results from clinical trials involving humans, and any associated safety concerns.
Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.
Full Text Sources:
Medical:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.